Does CANDESARTAN Cause Benign prostatic hyperplasia? 30 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Benign prostatic hyperplasia have been filed in association with CANDESARTAN. This represents 0.3% of all adverse event reports for CANDESARTAN.
30
Reports of Benign prostatic hyperplasia with CANDESARTAN
0.3%
of all CANDESARTAN reports
12
Deaths
27
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From CANDESARTAN?
Of the 30 reports, 12 (40.0%) resulted in death, 27 (90.0%) required hospitalization, and 11 (36.7%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANDESARTAN. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does CANDESARTAN Cause?
Off label use (1,911)
Fatigue (1,468)
Dyspnoea (1,456)
Pain (1,455)
Drug ineffective (1,428)
Headache (1,371)
Nausea (1,282)
Dizziness (1,237)
Vomiting (1,202)
Diarrhoea (1,145)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which CANDESARTAN Alternatives Have Lower Benign prostatic hyperplasia Risk?
CANDESARTAN vs CANDESARTAN CILEXETIL
CANDESARTAN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANDESARTAN vs CANGRELOR
CANDESARTAN vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN vs CANNABIDIOL